Notably, due to changes in their lipid and protein composition, the lysosomes of cancer cells are particularly vulnerable to treatments that induce lysosomal membrane permeabilization (LMP).2 Moreover, LMP can trigger cell death in cancer cells that lack components of the apoptotic machinery, thus providing a promising strategy to overcome resistance to certain therapies. The gene discussed is PDLIM7; the disease is cancer.